Suppr超能文献

颅底脑膜瘤的放射外科和立体定向放射治疗:一种分级系统的提议

Radiosurgery and stereotactic radiation therapy of skull base meningiomas: proposal of a grading system.

作者信息

De Salles A A, Frighetto L, Grande C V, Solberg T D, Cabatan-Awang C, Selch M T, Wallace R, Ford J

机构信息

Division of Neurosurgery and Department of Radiation Oncology, University of California, Los Angeles, CA 90095, USA.

出版信息

Stereotact Funct Neurosurg. 2001;76(3-4):218-29. doi: 10.1159/000066722.

Abstract

OBJECTIVE

The development of a grading system to guide treatment selection, and predict treatment difficulty and outcome of skull base meningiomas infiltrating the cavernous sinus which are managed by stereotactic radiosurgery (SRS) and stereotactic radiotherapy (SRT), based on an 8-year experience with stereotactic radiation of skull base meningiomas.

METHODS

T1 gadoliniun-enhanced magnetic resonance imaging (MRI) of 40 patients with skull base meningiomas, with or without prior surgery, who underwent radiosurgery or stereotactic radiation therapy from 1991 to 1998 at the UCLA Medical Center were reviewed, and the result of treatment was related to the tumor grade. Grade was based on tumor infiltration of the cavernous sinus and extension into adjacent structures. Treatment was performed with a linac-based system. The dose prescribed to the periphery of the tumor for SRS patients (n = 34) ranged from 12 to 22 Gy, and the maximum dose delivered to the tumor ranged from 24 to 46 Gy. SRT (n = 6). Treatment was planned using a single isocenter, usually prescribed to the 90% isodose volume, bringing the fractionation scheme to the maximal tolerance of the optic apparatus. The periphery dose ranged from 24 to 46 Gy with a maximum dose of 45 to 51 Gy. Clinical and MRI follow-up was performed every six months for the first 3 years and every year thereafter.

RESULTS

Grade I meningiomas were restricted to the cavernous sinus (n = 12). Grade II cavernous sinus meningiomas extended to the clivus and/or the petrous bone, without compression of the brainstem (n = 9). Grade III meningiomas had superior and/or anterior extension with compression of the optic nerve or tract (n = 9). Grade IV tumors compressed the brain stem (n = 8), and Grade V were bilateral lesions (n = 2). Tumor control rates were 90% for Grade I, 86% for Grade II, 86% for Grade III, 42% for Grade IV and no control for tumors Grade V. Complications were not related to tumor grade.

CONCLUSION

This grading system correlated with outcome and difficulty in planning radiosurgery. Failure of treatment was more likely to occur in patients with higher Grade tumors.

摘要

目的

基于对颅底脑膜瘤立体定向放射治疗8年的经验,制定一种分级系统,以指导治疗选择,并预测经立体定向放射外科手术(SRS)和立体定向放射治疗(SRT)治疗的侵犯海绵窦的颅底脑膜瘤的治疗难度和预后。

方法

回顾了1991年至1998年在加州大学洛杉矶分校医学中心接受放射外科手术或立体定向放射治疗的40例颅底脑膜瘤患者的T1加权钆增强磁共振成像(MRI),无论其是否曾接受过手术,分析治疗结果与肿瘤分级的关系。分级基于肿瘤对海绵窦的侵犯程度及向相邻结构的扩展情况。治疗采用直线加速器系统。SRS组(n = 34)患者肿瘤周边规定剂量为12至22 Gy,肿瘤接受的最大剂量为24至46 Gy。SRT组(n = 6)。治疗计划采用单一等中心,通常规定照射90%等剂量体积,使分割方案达到视器的最大耐受量。周边剂量为24至46 Gy,最大剂量为45至51 Gy。前3年每6个月进行一次临床和MRI随访,此后每年随访一次。

结果

I级脑膜瘤局限于海绵窦(n = 12)。II级海绵窦脑膜瘤扩展至斜坡和/或岩骨,未压迫脑干(n = 9)。III级脑膜瘤向上和/或向前扩展,压迫视神经或视束(n = 9)。IV级肿瘤压迫脑干(n = 8),V级为双侧病变(n = 2)。I级肿瘤控制率为90%,II级为86%,III级为86%,IV级为42%,V级肿瘤无控制病例。并发症与肿瘤分级无关。

结论

该分级系统与放射外科手术的预后和计划难度相关。高级别肿瘤患者更易出现治疗失败。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验